Atea Pharmaceuticals, Inc. (AVIR) Balance Sheet
As of 2026-06-30 (10-Q), Atea Pharmaceuticals, Inc. (AVIR) reported total assets of $232.3M and shareholders' equity of $204.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $76.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AVIRAtea Pharmaceuticals, Inc.Follow AVIR — free
—
Price chart with a free account
- Market cap
- 324.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 850.1 | 764.4 | 188.5 | 143.8 | 64.7 | 95.7 | 76.5 | |
| Short-term investments | — | — | 458.2 | 434.3 | 390.0 | 206.1 | 142.9 | |
| Current assets | 863.5 | 772.4 | 660.9 | 590.5 | 462.4 | 311.0 | 228.7 | |
| Total assets | 863.6 | 772.9 | 666.7 | 595.0 | 464.7 | 315.2 | 232.3 | |
| Current liabilities | 315.8 | 56.9 | 18.5 | 32.4 | 18.6 | 39.8 | 28.1 | |
| Total liabilities | 315.8 | 62.8 | 26.1 | 39.8 | 25.8 | 39.8 | — | |
| Shareholders' equity | 547.8 | 710.1 | 640.6 | 555.2 | 438.9 | 275.4 | 204.2 |
USD millions · SEC XBRL
Atea Pharmaceuticals, Inc. — questions
- How much cash does Atea Pharmaceuticals, Inc. have?
- $76.5M in cash and cash equivalents as of 2026-06-30.
- What are Atea Pharmaceuticals, Inc.'s total assets?
- $232.3M as of 2026-06-30.
- What is Atea Pharmaceuticals, Inc.'s shareholders' equity?
- $204.2M as of 2026-06-30.
Every figure on this page comes from Atea Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.